InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,131.83
(
1.34%
)
US TECH 100
17,423.56
(
2.04%
)
Dow Jones
38,673.99
(
1.17%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
61,700.85
(
4.36%
)
Post# of 458246
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

LakeshoreLeo1953

Send PM Follow Ignore
Followers 33
Posts 9784
Boards Moderated 0
Alias Born 02/26/2016

LakeshoreLeo1953

Re: McMagyar post# 116393

Monday, 08/21/2017 10:08:26 AM

Monday, August 21, 2017 10:08:26 AM

Post# of 458246
Proclaiming a dosage other than reported to FDA and announced by the Company as known is beyond ridiculous.

Safety as primary endpoint is equally the given and published trial
metric. The P3 WILL be efficacy in a meaningfully sized study.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!